Giving it the right name means researchers worldwide can finally talk about the same thing
Desde los laboratorios del Instituto de Salud Carlos III de España llega una claridad que la ciencia tardó años en alcanzar: lo que se creía una sola sombra parasitaria resulta ser dos. La confirmación de Babesia hegotelforum como especie propia, junto con nuevos hallazgos genómicos sobre B. divergens, no es solo un ajuste taxonómico, sino un reordenamiento del mapa con el que médicos e investigadores navegan una enfermedad transmitida por garrapatas que, en los más vulnerables, puede volverse devastadora. Nombrar correctamente lo que nos enferma es, a menudo, el primer acto de curación.
- Durante años, un parásito causante de babesiosis grave en humanos circuló en la literatura científica bajo un nombre provisional e impreciso, generando confusión diagnóstica y obstaculizando la investigación.
- Investigadores de Yale, en colaboración con el equipo español, han confirmado que Babesia hegotelforum es una especie completamente distinta de B. divergens, con su propia línea evolutiva y características biológicas propias.
- Un segundo estudio revela que el genoma de B. divergens contiene regiones de alta variabilidad genética que podrían explicar por qué la infección es leve en algunos pacientes y potencialmente mortal en ancianos e inmunodeprimidos.
- La nomenclatura oficial de B. hegotelforum despeja el camino para estudios más precisos sobre epidemiología, mecanismos de infección y tratamiento clínico en humanos y animales.
- El tratamiento actual combina antiparasitarios y antibióticos, pero el diagnóstico temprano sigue siendo crítico, y estas investigaciones ofrecen a los clínicos herramientas más afinadas para identificar qué especie enfrentan.
Una picadura de garrapata puede esconder más de un problema. Durante años, la ciencia sabía que el parásito Babesia causaba babesiosis —una enfermedad con fiebre, anemia y complicaciones graves en personas mayores e inmunodeprimidas— pero no sabía con precisión cuántas especies distintas estaban implicadas.
Investigadores del Instituto de Salud Carlos III de España acaban de publicar dos estudios que reconfiguran ese entendimiento. El primero, liderado desde la Universidad de Yale y publicado en Emerging Microbes & Infections, confirma que el organismo conocido provisionalmente como Babesia divergens-like MO1 es en realidad una especie independiente: Babesia hegotelforum. El nombre rinde homenaje a tres científicos clave en el estudio de la enfermedad. Más allá del gesto, la distinción es fundamental: B. hegotelforum no es una variante de B. divergens, sino un linaje evolutivo propio, con datos genómicos y biológicos que lo respaldan. Tener el nombre correcto para el organismo correcto es, en ciencia médica, el punto de partida de todo lo demás.
El segundo estudio, publicado en el International Journal of Molecular Sciences, examina cómo B. divergens ha evolucionado para adaptarse a distintos huéspedes. Al analizar una región específica del genoma del parásito en muestras de humanos y bovinos infectados, los investigadores encontraron un patrón revelador: algunas zonas genéticas permanecen estables entre muestras, mientras otras muestran una variabilidad notable. Esa flexibilidad genética podría explicar por qué el parásito logra infectar huéspedes tan distintos y por qué la enfermedad se manifiesta de forma tan diferente según la persona.
La babesiosis sigue siendo una enfermedad que exige vigilancia. Puede pasar desapercibida en personas sanas, pero en los más vulnerables representa una amenaza seria. Con la identificación formal de B. hegotelforum y una comprensión más profunda del genoma de B. divergens, clínicos e investigadores disponen ahora de una base más sólida para diagnosticar, estudiar y tratar esta infección zoonótica. Es el tipo de avance que no ocupa portadas, pero que desplaza silenciosamente los cimientos de la práctica médica.
A tick bite can carry more than one kind of trouble. For years, researchers have known that a parasite called Babesia causes babesiosis—a disease that arrives through the puncture wound of an infected tick and can trigger fever, anemia, and a general sense of being unwell. What they didn't know, until recently, was that they were looking at more than one culprit.
Scientists at Spain's Carlos III Health Institute have just published two studies that reshape what we understand about this parasitic infection, which behaves in some ways like malaria and spreads from animals to humans. The first study, led by researchers at Yale University and published in Emerging Microbes & Infections, confirms the existence of a previously unrecognized species of Babesia. The organism had been floating around in scientific literature under a provisional name—Babesia divergens-like MO1—but now it has an official designation: Babesia hegotelforum. The naming itself carries weight. It honors Barbara Herwaldt, Sam Telford III, and Heidi K. Goethert for their contributions to understanding this disease.
The distinction matters because B. hegotelforum is not simply a variant of B. divergens, the Babesia species already known to cause severe babesiosis in humans. Genetic analysis, phylogenomic data, and biological evidence collected over years show that this is a separate lineage entirely—a distinct organism with its own evolutionary path. For researchers trying to understand how the parasite works, how it spreads, and how to treat it, having the right name for the right organism is foundational. As the Spanish team explains, formal recognition will help clarify the scientific literature and accelerate progress in studying the biology, epidemiology, and clinical aspects of babesiosis in both animals and people.
The second study, published in the International Journal of Molecular Sciences, digs deeper into how B. divergens itself has evolved and adapted to different hosts. Researchers examined a specific region of the parasite's genome—the intergenic space between two genes that code for elongation factor 1-alpha—by analyzing samples taken from infected humans and cattle. What they found was a landscape of genetic variation. Some parts of this region were conserved across samples, suggesting evolutionary stability. Other parts showed significant variability, the kind of genetic flexibility that might allow the parasite to adjust to new hosts or change how it infects them.
These genomic differences could influence how the elongation factor is expressed, which in turn might determine key evolutionary characteristics that shape the parasite's relationship with its hosts and the severity of infection in humans. The work is still in the stage of proposing mechanisms rather than proving them, but it opens a path toward understanding why babesiosis affects different people differently and why some infections are mild while others turn severe.
Babesiosis itself remains a disease that demands attention. It can be asymptomatic or mild in some people, but in the elderly and immunocompromised, it can cause serious harm. Early diagnosis is critical. Treatment typically combines antiparasitic drugs with antibiotics. Now, with a clearer picture of the parasites involved and their genetic underpinnings, clinicians and researchers have better tools to identify which species they're dealing with and how to approach it. The formal recognition of B. hegotelforum and the genomic insights into B. divergens represent the kind of foundational work that, while it may not make headlines, quietly shifts the ground beneath medical practice.
Citações Notáveis
Formal recognition will help clarify the scientific literature and accelerate progress in studying the biology, epidemiology, and clinical aspects of babesiosis in both animals and people— Researchers at Spain's Carlos III Health Institute
A Conversa do Hearth Outra perspectiva sobre a história
Why does it matter that scientists gave this parasite a new name? Isn't it still the same organism?
Not quite. The organism was real all along, but it was being called by a placeholder name that grouped it with something it wasn't actually related to. Giving it the right name means researchers worldwide can now talk about the same thing without confusion. It's like finally labeling a file correctly so everyone can find it.
And the genomic work—what does that actually tell us about treating babesiosis?
Right now, it tells us where to look next. The researchers found regions of the parasite's genome that are stable and regions that vary wildly. That variability is probably how the parasite adapts to different hosts. If we understand those mechanisms, we might eventually find ways to disrupt them.
So this is still basic research, not a cure.
Yes. But basic research is where cures begin. You have to understand the enemy before you can defeat it.
Who gets babesiosis, and how worried should they be?
Anyone can get it from a tick bite, but elderly people and those with weakened immune systems face the worst outcomes. For most people, early diagnosis and treatment with the right drugs work well. The danger is when it goes undiagnosed.
What happens if someone doesn't get treated?
Untreated babesiosis can cause severe anemia, organ damage, and in the worst cases, death. That's why these researchers emphasize early diagnosis so strongly.